Delphine Dominique Marthe Lees

Title: Delphine Dominique Marthe Lees: Innovator in Endothelin-1 Synthesis Inhibition

Introduction

Delphine Dominique Marthe Lees is a prominent inventor based in London, GB. She has made significant contributions to the field of medical research, particularly in the area of endothelin-1 synthesis inhibition. Her innovative work aims to address diseases associated with the overproduction of endothelin-1, which can lead to various health complications.

Latest Patents

Delphine holds a patent for "Inhibitors of endothelin-1 synthesis." This patent describes sequences in human preproendothelin-1 mRNA that can be targeted by antisense oligonucleotides to inhibit the synthesis of endothelin-1. The inhibition of this synthesis has potential therapeutic applications for treating diseases where excess endothelin-1 production is a contributing factor to the symptoms.

Career Highlights

Delphine is affiliated with William Harvey Research Limited, where she continues her research and development efforts. Her work is crucial in advancing our understanding of endothelin-1 and its implications in various diseases.

Collaborations

Throughout her career, Delphine has collaborated with esteemed colleagues, including Roger Corder and Adrian P L Smith. These collaborations have further enriched her research and contributed to the advancement of medical science.

Conclusion

Delphine Dominique Marthe Lees is a trailblazer in the field of endothelin-1 synthesis inhibition. Her innovative patent and ongoing research efforts hold promise for developing new treatments for diseases linked to endothelin-1 overproduction.